OXAPROZIN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chartwell Rx, Llc.. The primary component is Oxaprozin.
| Product ID | 62135-176_e6fb1b0d-c87e-84bd-e053-2995a90a67a1 |
| NDC | 62135-176 |
| Product Type | Human Prescription Drug |
| Proprietary Name | OXAPROZIN |
| Generic Name | Oxaprozin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2004-09-02 |
| Marketing Category | ANDA / |
| Application Number | ANDA075987 |
| Labeler Name | Chartwell RX, LLC. |
| Substance Name | OXAPROZIN |
| Active Ingredient Strength | 600 mg/1 |
| Pharm Classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-08-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-0924 | Oxaprozin | Oxaprozin |
| 0185-0141 | Oxaprozin | Oxaprozin |
| 21695-100 | Oxaprozin | Oxaprozin |
| 50090-2012 | Oxaprozin | Oxaprozin |
| 50436-2899 | Oxaprozin | Oxaprozin |
| 52959-800 | Oxaprozin | Oxaprozin |
| 55111-170 | Oxaprozin | Oxaprozin |
| 55289-601 | Oxaprozin | Oxaprozin |
| 57664-391 | Oxaprozin | Oxaprozin |
| 59762-6002 | oxaprozin | oxaprozin |
| 60760-092 | Oxaprozin | Oxaprozin |
| 60760-203 | Oxaprozin | Oxaprozin |
| 60760-382 | Oxaprozin | Oxaprozin |
| 61919-178 | OXAPROZIN | OXAPROZIN |
| 61919-673 | OXAPROZIN | OXAPROZIN |
| 62135-176 | OXAPROZIN | OXAPROZIN |
| 68151-0523 | Oxaprozin | Oxaprozin |
| 69238-1120 | Oxaprozin | Oxaprozin |
| 70332-311 | Oxaprozin | Oxaprozin |
| 70332-310 | OXAPROZIN | OXAPROZIN |
| 71335-0617 | Oxaprozin | Oxaprozin |
| 71335-0393 | Oxaprozin | Oxaprozin |
| 71335-0902 | Oxaprozin | Oxaprozin |
| 63629-1345 | Oxaprozin | Oxaprozin |
| 66336-722 | Oxaprozin | Oxaprozin |
| 72189-077 | OXAPROZIN | OXAPROZIN |
| 0025-1381 | Daypro | oxaprozin |
| 55289-453 | Daypro | oxaprozin |